[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-371247-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-371247-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","fear-of-cancer-recurrence-is-associated-with-higher-primary-care-use-after-cancer-treatment-a-survey-administrative-health-data-linkage-study","Fear of cancer recurrence is associated with higher primary care use after cancer treatment: a survey-administrative health data linkage study","","Purpose examines whether fear of cancer recurrence (FCR) relates to healthcare utilization after completing cancer treatment. Methods use a population-based survey administered by the provincial cancer registry within a national study; Nova Scotian survivors of multiple cancer types, 1–3 years post-treatment, reported FCR severity via a single item. Survey responses were linked to registry, physicians’ claims, hospitalization, and ambulatory care for four years starting after diagnosis. Results: 38% reported FCR; younger survivors and females reported more. Adjusted analyses show FCR associated with 22% higher primary care use; no specialist visit differences. Conclusion highlights FCR as a prevalent ongoing effect increasing primary care follow-up visits.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/fear-of-cancer-recurrence-is-associated-with-higher-primary-care-use-after-cancer-treatment-a-survey-administrative-health-data-linkage-study/371247/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/fear-of-cancer-recurrence-is-associated-with-higher-primary-care-use-after-cancer-treatment-a-survey-administrative-health-data-linkage-study/371247.png","ImageObject",300,407,{"name":42,"@type":43},"Ivy","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How was fear of cancer recurrence (FCR) measured in the study?","Question",{"text":63,"@type":64},"FCR was assessed using a single survey item capturing both presence and severity of fear related to cancer coming back or progressing.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What patient group was analyzed?",{"text":68,"@type":64},"The final cohort included cancer survivors who completed the survey, had their administrative data linked, and were alive and cancer-free during the four-year follow-up period (n = 823).",{"name":70,"@type":61,"acceptedAnswer":71},"What healthcare use differences were found for participants with FCR?",{"text":72,"@type":64},"After adjusted analyses, FCR was associated with 22% higher primary care use, while no differences were found for specialist visits between those with and without FCR.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},371247,1790662904,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":123,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},549758252649,"https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819","Supportive Care in Cancer (2025) 33:172  \n[https://doi.org/10.1007/s00520-025-09242-x](https://doi.org/10.1007/s00520-025-09242-x)  \nFear of cancer recurrence is associated with higher primary care use after cancer treatment: a survey‑administrative health data linkage study  \nRobin Urquhart1,3 · Cynthia Kendell2 · Lynn Lethbridge3  \nReceived: 2 July 2024 / Accepted: 4 February 2025 / Published online: 11 February 2025 © The Author(s) 2025  \nAbstract  \nPurpose To examine the association between fear of cancer recurrence (FCR) and healthcare utilization after completing cancer treatment.  \nMethods A population-based survey to examine survivors’ experiences and needs after completing cancer treatment was administered by the provincial cancer registry as part of a national study. Respondents included Nova Scotian survivors of breast, melanoma, colorectal, prostate, hematologic, and young adult cancers who were 1–3 years post-treatment. FCR was assessed using a single item that captured presence and severity. Survey responses were linked to cancer registry, physicians’ claims, hospitalization, and ambulatory care data. The data linkage provided four years of healthcare utilization data for each cancer survivor, beginning 1 year after their cancer diagnosis. The final study cohort were cancer survivors who responded to the survey, had their data linked, completed the FCR survey items, and were alive and cancer-free during the 4-year follow-up period (n = 823). The data were analyzed descriptively and using regression models for count data analysis. Results Thirty-eight percent of respondents reported FCR. Younger respondents reported higher levels of FCR compared to older respondents: for example, 66.1% of respondents age 18–54 years reported FCR whereas 24.4% of respondents age 75 years and older reported FCR. More females than males reported FCR. Upon adjusted analyses, FCR was associated with 22% higher primary care use after cancer treatment (incidence rate ratio = 1.22, 95% confidence interval = 1.19–1.25, p \u003C 0.0001). No differences were found for specialist visits between those with FCR and those with no FCR (p = 0.366) . Conclusion FCR is a highly prevalent ongoing effect for those who complete cancer treatment. Cancer survivors who reported FCR visited their primary care providers more during follow-up care than those without FCR.  \nKeywords Fear of cancer recurrence · Survey · Administrative health data · Primary care  \nBackground  \nCancer survival has improved dramatically and the prevalence of cancer survivors is increasing [1, 2] . In 2018, more than 1.5 million Canadians who were diagnosed with cancer  \n* Robin Urquhart [robin.urquhart@nshealth.ca](robin.urquhart@nshealth.ca)  \n1 Department of Community Health and Epidemiology, Centennial Building, VG Site, Dalhousie University, Rm 8-0321276 South Park Street, Halifax, NS, Canada  \n2 Department of Medicine, Dalhousie University/Nova Scotia Health, Halifax, NS, Canada  \n3 Department of Surgery, Dalhousie University/Nova Scotia Health, Halifax, NS, Canada  \nin the previous 25 years were still living with or beyond cancer; breast, prostate, and colorectal cancers accounted for nearly half (48.5%) of these cancers [3] . This reflects tremendous success in early detection and cancer therapies. Despite enhanced survival, many survivors experience substantial ongoing needs due to their cancer and/or its treatment [4, 5] . Fear of cancer recurrence (FCR) is one of the most common unmet needs after curative-intent cancer treatment [4, 6] . Defined as “fear, worry, or concern relating to the possibility that cancer will come back or progress” [7], a recent systematic review and individual participant data meta-analysis on the prevalence ofFCR found that >50% of cancer survivors experience sub-clinical or clinical FCR at some point during and/or after completing primary treatment [8]. FCR is associated with high distress, impaired functioning, maladaptive coping strategies, and ","cbCainfxGC7HaFba","https://ap.wps.com/l/cbCainfxGC7HaFba","pdf",629615,"English","# Abstract\n# Background\n# Methods\n## Setting","[{\"question\":\"How was fear of cancer recurrence (FCR) measured in the study?\",\"answer\":\"FCR was assessed using a single survey item capturing both presence and severity of fear related to cancer coming back or progressing.\"},{\"question\":\"What patient group was analyzed?\",\"answer\":\"The final cohort included cancer survivors who completed the survey, had their administrative data linked, and were alive and cancer-free during the four-year follow-up period (n = 823).\"},{\"question\":\"What healthcare use differences were found for participants with FCR?\",\"answer\":\"After adjusted analyses, FCR was associated with 22% higher primary care use, while no differences were found for specialist visits between those with and without FCR.\"}]","Fear of cancer recurrence is associated with higher primary care use after cancer treatment: a survey-administrative health data linkage study | PDF",1790191615,25,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4979fe0081220658a217a2ed4a15db00.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b15709471e416f49aae82f3f5143e4a2.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3454d8e827f0352df2696c61e893ea93.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/973f574506f2631913006bdf9a6c067b.webp",980,1301]